Publicaciones en colaboración con investigadores/as de Hospital Clinico Universitario de Valencia (26)

2022

  1. A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

    Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 93-100

2020

  1. Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document

    Bone Marrow Transplantation, Vol. 55, Núm. 4, pp. 811-817

2019

  1. Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

    British Journal of Haematology, Vol. 184, Núm. 5, pp. 797-807

  2. Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial

    Cancer Medicine, Vol. 8, Núm. 16, pp. 6955-6966

2018

  1. A phase ii multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

    Haematologica, Vol. 103, Núm. 8, pp. 1351-1358

2013

  1. First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with 90Y-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group

    Haematologica, Vol. 98, Núm. 10, pp. 1563-1570

2009

  1. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis

    Oncogene, Vol. 28, Núm. 17, pp. 1892-1903

2008

  1. Nutritional recommendations in hematopoietic stem cell transplantation

    Nutrition, Vol. 24, Núm. 7-8, pp. 769-775

2006

  1. Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin lymphoma: Results of a Spanish prospective cooperative protocol

    Biology of Blood and Marrow Transplantation, Vol. 12, Núm. 2, pp. 172-183

2005

  1. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells

    Cancer Research, Vol. 65, Núm. 8, pp. 3264-3272

2004

  1. Biología de la leucemia linfática crónica B

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular

2003

  1. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study

    Leukemia, Vol. 17, Núm. 10, pp. 2016-2024

  2. Imatinib mesylate (STI571) treatment in patients with chronic-phase chronic myelogenous leukaemia previously submitted to autologous stem cell transplantation

    British Journal of Haematology, Vol. 120, Núm. 3, pp. 500-504

  3. Nuevas tecnologías y su significado diagnóstico en los linfomas. Versión definitiva. Microarrays de ADN

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular

  4. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: Association with clinical characteristics and outcome

    Annals of Oncology, Vol. 14, Núm. 3, pp. 467-474

2002

  1. De la citogenética al estudio con microarrays en los linfomas

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 5, Núm. 1, pp. 81-82

  2. Enfermedad medular linfoproliferativa crónica B rica en linfocitos T

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 5, Núm. 1, pp. 1-4

  3. NH2-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer

    Clinical Cancer Research, Vol. 8, Núm. 2, pp. 347-353

2001

  1. Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features

    Hematology Journal, Vol. 2, Núm. 4, pp. 234-241

  2. Novel genomic imbalances in b-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics

    American Journal of Pathology, Vol. 158, Núm. 5, pp. 1843-1850